Amendment and Mail Process Complete

OPPORTUNITIES FOR A BETTER LIFE

NoNO Inc.

Amendment and Mail Process Complete

Trademark Snap Shot Amendment & Mail Processing Stylesheet
(Table presents the data on Amendment & Mail Processing Complete)

OVERVIEW

SERIAL NUMBER 88299385 FILING DATE 02/13/2019
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY FRENCH, CURTIS W
L.O. ASSIGNED O30-NOT FOUND

PUB INFORMATION

RUN DATE 05/28/2020
PUB DATE N/A
STATUS 661-RESPONSE AFTER NON-FINAL-ACTION-ENTERED
STATUS DATE 05/27/2020
LITERAL MARK ELEMENT OPPORTUNITIES FOR A BETTER LIFE

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D YES 44D YES 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT OPPORTUNITIES FOR A BETTER LIFE
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME NoNO Inc.
ADDRESS 479A Wellington Street West
Toronto, Ontario, M5V1E7
ENTITY 03-CORPORATION
CITIZENSHIP Canada

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Pharmaceutical preparations for human or animal use, namely, pharmaceuticals for the treatment of neurological disease, pharmaceuticals for the treatment of cardiovascular diseases, pharmaceuticals for the treatment of ischemia, pharmaceuticals for the treatment of stroke, pharmaceuticals for the treatment of neuronal injury, and pharmaceuticals for the treatment of neurodegenerative diseases
INTERNATIONAL CLASS 041
          DESCRIPTION TEXT Educational services, namely, conducting conferences, seminars, webinars, video case studies, classes and workshops in the fields of healthcare, pharmaceuticals and medicine, pharmaceutical research and development
INTERNATIONAL CLASS 044
          DESCRIPTION TEXT Providing a website featuring medical and health information; providing a website featuring medical and health information in the field of the prophylactic and therapeutic properties of pharmaceuticals; providing health information; providing patients with health and medical information; counseling and charitable services for patients, namely, providing medical and health information and health informational assistance with respect to obtaining prescription medications

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 041 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 044 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO


FOREIGN INFORMATION
PRIORITY CLAIMED SEC. 44(D) ON Canada
APPLICATION NO. 1945794
APPLICATION FILING DATE 02/12/2019
FOREIGN REG NO. N/A
FOREIGN REG DATE N/A
FOREIGN RNWL NUM N/A
DATE OF FOREIGN RNWL N/A
FOREIGN EXPIRATION N/A
FOREIGN RNWL EXPIRATION N/A

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
05/27/2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 024
05/27/2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 023
05/26/2020 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED 022
12/02/2019 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED 021
12/02/2019 GNSI S INQUIRY TO SUSPENSION E-MAILED 020
12/02/2019 CNSI R SUSPENSION INQUIRY WRITTEN 019
11/20/2019 RCCK S LIE CHECKED SUSP - TO ATTY FOR ACTION 018
11/15/2019 ALIE A ASSIGNED TO LIE 017
06/07/2019 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED 016
06/07/2019 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED 015
04/24/2019 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED 014
04/24/2019 GNSL S LETTER OF SUSPENSION E-MAILED 013
04/24/2019 CNSL R SUSPENSION LETTER WRITTEN 012
04/05/2019 XAEC I EXAMINER'S AMENDMENT ENTERED 011
04/05/2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED 010
04/05/2019 GNEA O EXAMINERS AMENDMENT E-MAILED 009
04/05/2019 CNEA R EXAMINERS AMENDMENT -WRITTEN 008
04/02/2019 XAEC I EXAMINER'S AMENDMENT ENTERED 007
04/02/2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED 006
04/02/2019 GNEA F EXAMINERS AMENDMENT E-MAILED 005
04/02/2019 CNEA R EXAMINERS AMENDMENT -WRITTEN 004
04/02/2019 DOCK D ASSIGNED TO EXAMINER 003
03/06/2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
02/16/2019 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY James M. Urzedowski
CORRESPONDENCE ADDRESS James M. Urzedowski
TYSVER BECK EVANS
225 SOUTH 6TH STREET
SUITE 1750
MINNEAPOLIS, MN 55402
DOMESTIC REPRESENTATIVE NONE

Amendment and Mail Process Complete [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed